CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS FOR STAKEHOLDERS
1.3. KEY PLAYERS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. KEY FINDINGS OF THE STUDY
2.2. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top wining strategies
3.2.1.1. Competitive intelligence and strategies of companies
3.2.2. Top investment pockets
3.3. MARKET DYNAMICS
3.3.1. Drivers
3.3.1.1. Increasing incidence of crime
3.3.1.2. Technological advancements
3.3.1.3. Advantages in forensic technology
3.3.1.4. Increased funding for forensic research
3.3.2. Restraints
3.3.2.1. Lack of accuracy in results
3.3.3. Opportunities
3.3.3.1. Government initiatives to prevent cybercrime by using forensic science
3.3.4. Impact analysis
3.4. FUNDING INITIATIVES
3.5. REGULATIONS
CHAPTER 4 FORENSIC TECHNOLOGIES MARKET, BY SERVICE
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. DNA PROFILING
4.2.1. Market size and forecast
4.3. FINGERPRINTING ANALYSIS
4.3.1. Market size and forecast
4.4. CHEMICAL ANALYSIS
4.4.1. Market size and forecast
4.5. FIREARM ANALYSIS
4.5.1. Market size and forecast
4.6. OTHERS
4.6.1. Market size and forecast
CHAPTER 5 FORENSIC TECHNOLOGIES MARKET, BY PRODUCT
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. DNA TESTING
5.2.1. Key market trends
5.2.2. Key growth factors and opportunities
5.2.3. Market size and forecast
5.3. BIOMETRIC DEVICES
5.3.1. Key market trends
5.3.2. Key growth factors and opportunities
5.3.3. Market size and forecast
5.4. DIGITAL FORENSICS
5.4.1. Key market trends
5.4.2. Key growth factors and opportunities
5.4.3. Market size and forecast
5.5. BALLISTIC FORENSICS
5.5.1. Key market trends
5.5.2. Key growth factors and opportunities
5.5.3. Market size and forecast
5.6. OTHERS
5.6.1. Key market trends
5.6.2. Key growth factors and opportunities
5.6.3. Market size and forecast
CHAPTER 6 FORENSIC TECHNOLOGY MARKET, BY REGION
6.1. OVERVIEW
6.1.1. Market size and forecast
6.2. NORTH AMERICA
6.2.1. Key market trends
6.2.2. Growth factors and opportunities
6.2.3. Market size and forecast
6.2.4. U.S. market size and forecast
6.2.5. Canada market size and forecast
6.2.6. Mexico market size and forecast
6.3. EUROPE
6.3.1. Key market trends
6.3.2. Growth factors and opportunities
6.3.3. Market size and forecast
6.3.4. UK market size and forecast
6.3.5. Germany market size and forecast
6.3.6. Spain market size and forecast
6.3.7. Italy market size and forecast
6.3.8. France market size and forecast
6.3.9. Rest of Europe market size and forecast
6.4. ASIA-PACIFIC
6.4.1. Key market trends
6.4.2. Growth factors and opportunities
6.4.3. Market size and forecast
6.4.4. Japan market size and forecast
6.4.5. China market size and forecast
6.4.6. India market size and forecast
6.4.7. Australia market size and forecast
6.4.8. Rest of Asia-Pacific market size and forecast
6.5. LAMEA
6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast
6.5.4. Brazil market size and forecast
6.5.5. Saudi Arabia market size and forecast
6.5.6. South Africa market size and forecast
6.5.7. Rest of LAMEA market size and forecast
CHAPTER 7 COMPANY PROFILES
7.1. 3M COMPANY
7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Product Portfolio
7.1.5. Business performance
7.1.6. Key strategic moves and developments
7.2. AGILENT TECHNOLOGIES INC.
7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product portfolio
7.2.5. Business performance
7.2.6. Key strategic moves and developments
7.3. BELKASOFT
7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Product portfolio
7.3.5. Key strategic moves and developments
7.4. GE HEALTHCARE (A HEALTHCARE DIVISION OF GE COMPANY)
7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Product portfolio
7.4.5. Business performance
7.4.6. Key strategic moves and developments
7.5. EUROFINS MEDIGENOMIX FORENSIK GMBH (FORENSIC DIVISION OF EUROFINS SCIENTIFIC S.E.)
7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Product portfolio
7.5.5. Business performance
7.5.6. Key strategic moves and developments
7.6. LGC LIMITED
7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Product portfolio
7.6.5. Key strategic moves and developments
7.7. MORPHOTRUST USA (SAFRAN S.A.)
7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Product portfolio
7.7.5. Business performance
7.8. NMS LABS
7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Product portfolio
7.9. THERMO FISHER SCIENTIFIC INC.
7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Product portfolio
7.9.5. Business performance
7.9.6. Key strategic moves and developments
7.10. ULTRA ELECTRONICS FORENSIC TECHNOLOGY INC. (SUBSIDIARY OF ULTRA ELECTRONICS HOLDINGS PLC.)
7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segments
7.10.4. Product portfolio
7.10.5. Business performance
7.10.6. Key strategic moves and developments